Analysts have set 12-month price targets for Penumbra, revealing an average target of $313.83, a high estimate of $340.00, ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

Acute ischemic stroke (AIS) is the leading cause of adult disability in the United States and a major cause of death both ...

The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027. These devices are used in ...

There is increased risk for ischemic stroke in patients diagnosed with atrial fibrillation at a younger age. Younger individuals diagnosed with atrial fibrillation (AF) have a higher risk for ...

According to experts, inclement weather takes a toll on all your organs, especially if you have an underlying medical condition and low immunity. Scorching summertime increases the risk of eye ...

A new analysis finds a significant uptick in the number of people dying at home due to ischemic stroke compared to inpatient medical facilities, and when not at home, individuals in rural ...

The ANA funnel catheter is designed for use during stent retriever-based thrombectomy to facilitate clot removal by restricting flow during retrieval, enabling simultaneous aspiration, and reducing ...

If you’re on the fence about investing in Penumbra, Inc. or PROCEPT BioRobotics Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

If you’re on the fence about investing in Integer Holdings Corporation, Penumbra or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

Penumbra, Inc.’s PEN thrombectomy business is thriving, driven by growing sales of the U.S. vascular thrombectomy and CAVT (computer-assisted vacuum thrombectomy) line of products. The company’s ...